Kefang Liu Faculty of Health Sciences University of Macau Biography Publications Institution JoVE Articles Kefang Liu has not added a biography. If you are Kefang Liu and would like to personalize this page please email our Author Liaison for assistance. Publications Cross-species Recognition of SARS-CoV-2 to Bat ACE2 Proceedings of the National Academy of Sciences of the United States of America. 01, 2021 | Pubmed ID: 33335073 N-glycosylation of PD-1 Promotes Binding of Camrelizumab EMBO Reports. 12, 2020 | Pubmed ID: 33063473 Broad Host Range of SARS-CoV-2 and the Molecular Basis for SARS-CoV-2 Binding to Cat ACE2 Cell Discovery. 2020 | Pubmed ID: 33020722 Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1 Journal of Virology. 08, 2020 | Pubmed ID: 32522857 Peptide Presentation by Bat MHC Class I Provides New Insight into the Antiviral Immunity of Bats PLoS Biology. 09, 2019 | Pubmed ID: 31498797 Divergent Peptide Presentations of HLA-A30 Alleles Revealed by Structures With Pathogen Peptides Frontiers in Immunology. 2019 | Pubmed ID: 31396224 Heterosubtypic Protections Against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses MBio. Aug, 2018 | Pubmed ID: 30087171 Distinct PD-L1 Binding Characteristics of Therapeutic Monoclonal Antibody Durvalumab Protein & Cell. Jan, 2018 | Pubmed ID: 28488247 Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC Journal of Immunology (Baltimore, Md. : 1950). 01, 2017 | Pubmed ID: 27903740 T-cell Immunity of SARS-CoV: Implications for Vaccine Development Against MERS-CoV Antiviral Research. 01, 2017 | Pubmed ID: 27840203 Structural Basis of Anti-PD-L1 Monoclonal Antibody Avelumab for Tumor Therapy Cell Research. Jan, 2017 | Pubmed ID: 27573173 Crystal Clear: Visualizing the Intervention Mechanism of the PD-1/PD-L1 Interaction by Two Cancer Therapeutic Monoclonal Antibodies Protein & Cell. Dec, 2016 | Pubmed ID: 27815822 Estabilidade e Estrutura do Complexo de Histocompatibilidade Maior do Morcego Classe I com β Heterologous2-Microglobulina Di Zhang*1,2, Kefang Liu*3,4, Dan Lu*2,5, Pengyan Wang1,2, Qingxu Zhang1,2, Peipei Liu2, Yingze Zhao2, Yan Chai4, Jianxin Lyu1, Jianxun Qi4, William J. Liu1,2 1School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 2NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 3Faculty of Health Sciences, University of Macau, 4CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 5Savaid Medical School, University of Chinese Academy of Sciences JoVE 61462 Immunology and Infection Avaliação das respostas de células T Zika vírus específicos em órgãos Immunoprivileged de infectados Ifnar1- / - ratos Yongli Zhang*1,2, Hangjie Zhang*2, Wenqiang Ma*3, Kefang Liu1,2, Min Zhao4, Yingze Zhao2, Xuancheng Lu5, Fuping Zhang6, Xiangdong Li3, George F. Gao1,2,4,6, William J. Liu1,2 1School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 2NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 3State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, 4Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, 5Laboratory Animal Center, Chinese Center for Disease Control and Prevention, 6CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences JoVE 58110 Immunology and Infection
Estabilidade e Estrutura do Complexo de Histocompatibilidade Maior do Morcego Classe I com β Heterologous2-Microglobulina Di Zhang*1,2, Kefang Liu*3,4, Dan Lu*2,5, Pengyan Wang1,2, Qingxu Zhang1,2, Peipei Liu2, Yingze Zhao2, Yan Chai4, Jianxin Lyu1, Jianxun Qi4, William J. Liu1,2 1School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 2NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 3Faculty of Health Sciences, University of Macau, 4CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 5Savaid Medical School, University of Chinese Academy of Sciences JoVE 61462 Immunology and Infection
Avaliação das respostas de células T Zika vírus específicos em órgãos Immunoprivileged de infectados Ifnar1- / - ratos Yongli Zhang*1,2, Hangjie Zhang*2, Wenqiang Ma*3, Kefang Liu1,2, Min Zhao4, Yingze Zhao2, Xuancheng Lu5, Fuping Zhang6, Xiangdong Li3, George F. Gao1,2,4,6, William J. Liu1,2 1School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, 2NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 3State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, 4Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, 5Laboratory Animal Center, Chinese Center for Disease Control and Prevention, 6CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences JoVE 58110 Immunology and Infection
